Prevention of diabetes: Lifestyle and metformin are the way forward [12]

British Medical Journal

Volumn 333, Issue 7574, 2006, Pages 918-919

  Ashcroft, John S ^a  

^a Old Station Surgery   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

METFORMIN; ROSIGLITAZONE;

DIABETES MELLITUS; DRUG COST; HEALTH CARE COST; HUMAN; LETTER; LIFESTYLE; MORTALITY; PRIORITY JOURNAL;

DIABETES MELLITUS; HUMANS; HYPOGLYCEMIC AGENTS; LIFE STYLE; METFORMIN;

EID: 33750586210     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (4)

1. Heneghan C, Thompson M, Perera R. Prevention of diabetes. BMJ 2006;333:764-5. (14 October.)
2. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403
3. DREAM (diabetes reduction assessment with ramipril and rosiglitazone medication) Trial Investigators; Gerstein HC, Yusuf S, Bosch J, Pogue J, Sheridan P, Dinccag N, et al. Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. Lancet 2006;368:1096-105.
4. UK Prospective Diabetes Study. Lancet 1998;352:854-65.